Detalhe da pesquisa
1.
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Cell
; 183(2): 347-362.e24, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064988
2.
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Cell
; 172(4): 825-840.e18, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336888
3.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Cell
; 165(1): 35-44, 2016 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26997480
4.
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
; 615(7953): 687-696, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356599
5.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Nature
; 615(7953): 697-704, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890230
6.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Cell
; 168(3): 542, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129544
7.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870955
8.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856617
9.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261444
10.
High response rate to PD-1 blockade in desmoplastic melanomas.
Nature
; 553(7688): 347-350, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320474
11.
Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.
Ann Surg Oncol
; 30(5): 3097-3103, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581724
12.
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Future Oncol
; 18(12): 1449-1459, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040698
13.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
J Natl Compr Canc Netw
; 19(4): 364-376, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845460
14.
Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies.
Curr Treat Options Oncol
; 22(1): 9, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400014
15.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855868
16.
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis.
J Natl Compr Canc Netw
; 18(8): 1055-1065, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755981
17.
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Nature
; 515(7528): 568-71, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428505
18.
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
Cancer
; 125(14): 2445-2454, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034598
19.
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
N Engl J Med
; 375(9): 819-29, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27433843
20.
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
N Engl J Med
; 373(5): 428-37, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222558